PubMed ID:
17327345
Public Release Type:
Journal
Publication Year: 2007
Affiliation: Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ, UK. eric.kilpatrick@hey.nhs.uk
DOI:
https://doi.org/10.2337/dc06-1982
Authors:
Atkin SL,
Kilpatrick ES,
Rigby AS
Studies:
Diabetes Control and Complications Trial
The presence of insulin resistance and the metabolic syndrome are known risk markers for macrovascular disease in patients with and without type 2 diabetes. This study has examined whether these also were predictors of micro- and macrovascular complications in type 1 diabetic patients participating in the Diabetes Control and Complications Trial (DCCT).